HomeTOP STORIESNektar Therapeutics Non-GAAP EPS of $0.15 beats by $0.35, revenue of $29.17M... Nektar Therapeutics Non-GAAP EPS of $0.15 beats by $0.35, revenue of $29.17M misses by $7.49M By rogerjudd March 12, 2025 FacebookTwitterPinterestWhatsApp Post Content Previous articleFreightCar America Non-GAAP EPS of $0.21 beats by $0.17, revenue of $137.7M misses by $14.32MNext articleStocks Rally As Inflation Cools: Berkshire Hathaway, DoorDash, AU In Focus | Stock Market Today latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
